Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Stock Price Down 6.4%

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) shares were down 6.4% during mid-day trading on Tuesday . The company traded as low as $2.51 and last traded at $2.63, approximately 3,332,942 shares changed hands during mid-day trading. An increase of 139% from the average daily volume of 1,397,051 shares. The stock had previously closed at $2.81.

Separately, Zacks Investment Research upgraded Flagstar Bancorp from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research note on Monday, July 8th.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its earnings results on Tuesday, May 7th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.05). The company had revenue of $3.04 million during the quarter, compared to analysts’ expectations of $2.90 million.

A number of hedge funds and other institutional investors have recently modified their holdings of CVRS. Weiss Asset Management LP acquired a new stake in shares of Corindus Vascular Robotics during the first quarter worth about $65,000. Hudson Executive Capital LP lifted its holdings in shares of Corindus Vascular Robotics by 25.6% during the first quarter. Hudson Executive Capital LP now owns 14,235,545 shares of the medical equipment provider’s stock worth $24,770,000 after purchasing an additional 2,899,391 shares during the period. EAM Global Investors LLC acquired a new stake in shares of Corindus Vascular Robotics during the first quarter worth about $1,024,000. Independent Advisor Alliance acquired a new stake in shares of Corindus Vascular Robotics during the first quarter worth about $75,000. Finally, First Republic Investment Management Inc. acquired a new stake in shares of Corindus Vascular Robotics during the first quarter worth about $122,000.

About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.

Featured Article: Why do companies issue convertible shares?

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.